This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
HCA Healthcare (HCA) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 23.56% and 1.97%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
HCA Healthcare (HCA) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter results are likely to reflect the impacts of increased inpatient and outpatient surgery cases.
Universal Health Services (UHS) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stocks Take a Breather as Inflation Rate of Change Continues to Slow
by Mayur Thaker
All eyes now shift to Q1 earnings and management commentary on forward guidance.
Earnings Preview: HCA Healthcare (HCA) Q1 Earnings Expected to Decline
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Sector ETFs & Stocks That Show Promise After March Jobs Data
by Sanghamitra Saha
The United States economy added 236,000 jobs in March, the least since December of 2020, and compared to forecasts of 239,000.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare are part of the Zacks Industry Outlook article.
4 Stocks in Focus as Hospital Industry Witnesses Improvement
by Kaibalya Pravo Dey
Easing staffing challenges and technological adoption are aiding the margins of the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Acadia (ACHC) and Tenet Healthcare (THC) are poised to gain from improving volumes.
Here's Why You Should Retain McKesson (MCK) Stock for Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
HCA Healthcare (HCA) Expands in Kansas With a Medical Plaza
by Zacks Equity Research
HCA Midwest, run by HCA Healthcare (HCA), plans to add a two-story medical plaza in Overland Park of $12 million, to be occupied by Family Health Medical Group and Town Plaza Women's Care.
Here's Why You Should Retain HCA Healthcare (HCA) Stock Now
by Zacks Equity Research
HCA Healthcare (HCA) remains well-poised for growth on the back of improved revenues, a well-diversified healthcare portfolio and sufficient cash-generating abilities.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Here's Why You Should Retain McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
The Zacks Analyst Blog Highlights Enbridge, U.S. Bank, HCA Healthcare, Hershey's and American International
by Zacks Equity Research
Enbridge, U.S. Bank, HCA Healthcare, Hershey's and American International are included in this Analyst Blog.
Top Stock Reports for Enbridge, U.S. Bancorp & HCA Healthcare
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Enbridge Inc. (ENB), U.S. Bancorp (USB) and HCA Healthcare, Inc. (HCA).
Acadia Healthcare (ACHC) Gains From Expansion Initiatives
by Zacks Equity Research
Acadia Healthcare (ACHC) gains from solid top line stemming from continuous bed additions and higher patient volumes. A credible financial position drives its expansion endeavors.
Select Medical (SEM) Q4 Earnings Miss Estimates, Revenues Up
by Zacks Equity Research
Select Medical (SEM) anticipates 2023 revenues to be within $6.5-$6.7 billion.
Pediatrix (MD) Q4 Earnings miss on High Operating Expenses
by Zacks Equity Research
Pediatrix (MD) anticipates 2023 adjusted EBITDA to be within $235-$245 million.
The Zacks Analyst Blog Highlights Walmart, Alibaba Group Holding, Salesforce, HCA Healthcare and MetLife
by Zacks Equity Research
Walmart, Alibaba Group Holding, Salesforce, HCA Healthcare and MetLife are included in this Analyst Blog.
The Zacks Analyst Blog Highlights HCA Healthcare, Booz Allen Hamilton, GATX, NXP Semiconductors and MSCI
by Zacks Equity Research
HCA Healthcare, Booz Allen Hamilton, GATX, NXP Semiconductors and MSCI are included in this Analyst Blog.
Top Research Reports for Walmart, Alibaba & Salesforce
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Alibaba Group Holding Limited (BABA) and Salesforce, Inc. (CRM).
Watch These 5 Stocks That Recently Hiked Their Dividends
by Nalak Das
Dividend-paying stocks should be in demand as investors will try to safeguard their portfolios. Five such stocks are: HCA, BAH, GATX, NXPI and MSCI.
HCA Healthcare (HCA) Q4 Earnings Lag on High Costs, Hikes Dividend
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter results suffer a blow from added expenses incurred due to Hurricane Ian. Increased patient admissions partly offset the downside.
Here's How Much You'd Have If You Invested $1000 in HCA Healthcare a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.